Showing results (101-110 of 153) with videos related to
Sort By:
Pageof 16
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2016
Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think TankWorta McCaskill-Stevens, Deborah C Pearson, Barnett S Kramer, et al.Journal of the National Cancer Institute|February 10, 2015
Conceptualizing overdiagnosis in cancer screeningPamela M Marcus, Philip C Prorok, Anthony B Miller, et al.Nature Reviews. Clinical Oncology|April 14, 2016
Population-based screening for cancer: hope and hypeYiwey Shieh, Martin Eklund, George F Sawaya, et al.Cancer|November 6, 2004
Diagnostic procedures after a positive spiral computed tomography lung carcinoma screenPaul F Pinsky, Pamela M Marcus, Barnett S Kramer, et al.BJU International|October 28, 2010
5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic reviewTimothy J Wilt, Roderick Macdonald, Karen Hagerty, et al.Reviews on Recent Clinical Trials|April 10, 2018
Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening TrialPhilip C Prorok, Patrick Wright, Thomas R Riley, et al.Journal of Medical Screening|May 10, 2017
Incidental renal tumours on low-dose CT lung cancer screening examsPaul F Pinsky, Barbara Dunn, David Gierada, et al.The Journal of Urology|February 16, 2005
Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trialPaul F Pinsky, Gerald L Andriole, Barnett S Kramer, et al.JNCI Cancer Spectrum|April 16, 2021
DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology SettingsWynne E Norton, Worta McCaskill-Stevens, David A Chambers, et al.Cancer|March 3, 2007
Prostate-specific antigen velocity and prostate cancer gleason grade and stagePaul F Pinsky, Gerald Andriole, E David Crawford, et al.Pageof 16